These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16379190

  • 21. Re: Factors associated with low immunity to rubella infection on antenatal screening.
    Francis B, Thomas A, Haverkamp M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):172. PubMed ID: 16638048
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S.
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [Abstract] [Full Text] [Related]

  • 23. Rubella susceptibility among prenatal and family planning clinic populations.
    Dorfman SF, Bowers CH.
    Mt Sinai J Med; 1985 Apr; 52(4):248-52. PubMed ID: 3873601
    [Abstract] [Full Text] [Related]

  • 24. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S.
    Vaccine; 2007 May 04; 25(18):3615-8. PubMed ID: 17280747
    [Abstract] [Full Text] [Related]

  • 25. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ, Huang LM, Chen HH, Hwang KC, Chen CJ.
    J Med Virol; 2007 Jan 04; 79(1):97-103. PubMed ID: 17133552
    [Abstract] [Full Text] [Related]

  • 26. Rubella seroprevalence in women in the reproductive period, Mersin, Turkey.
    Sasmaz T, Kurt AO, Ozturk C, Bugdayci R, Oner S.
    Vaccine; 2007 Jan 15; 25(5):912-7. PubMed ID: 17049680
    [Abstract] [Full Text] [Related]

  • 27. Surveillance of congenital rubella syndrome in Japan, 1978-2002: effect of revision of the immunization law.
    Katow S.
    Vaccine; 2004 Sep 28; 22(29-30):4084-91. PubMed ID: 15364460
    [Abstract] [Full Text] [Related]

  • 28. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM, Flowers CA, Congdon CL.
    Obstet Gynecol; 2005 Aug 28; 106(2):295-300. PubMed ID: 16055578
    [Abstract] [Full Text] [Related]

  • 29. Antenatal rubella immunity in Ireland.
    O'Dwyer V, Bonham S, Mulligan A, O'Connor C, Farah N, Kennelly MM, Turner MJ.
    Ir Med J; 2013 Sep 28; 106(8):232-5. PubMed ID: 24282891
    [Abstract] [Full Text] [Related]

  • 30. Optimum use of rubella immunization.
    Mayer TR.
    Am Fam Physician; 1981 Jan 28; 23(1):143-5. PubMed ID: 7457312
    [Abstract] [Full Text] [Related]

  • 31. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.
    Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S664-8. PubMed ID: 21954264
    [Abstract] [Full Text] [Related]

  • 32. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL.
    Bull World Health Organ; 1997 Sep 01; 75(1):69-80. PubMed ID: 9141752
    [Abstract] [Full Text] [Related]

  • 33. Seroprevalence of rubella in the cord blood of pregnant women and congenital rubella incidence in Nha Trang, Vietnam.
    Miyakawa M, Yoshino H, Yoshida LM, Vynnycky E, Motomura H, Tho le H, Thiem VD, Ariyoshi K, Anh DD, Moriuchi H.
    Vaccine; 2014 Feb 26; 32(10):1192-8. PubMed ID: 24021315
    [Abstract] [Full Text] [Related]

  • 34. Seroprevalence of rubella among pregnant women in Khartoum state, Sudan.
    Adam O, Makkawi T, Kannan A, Osman ME.
    East Mediterr Health J; 2013 Sep 26; 19(9):812-5. PubMed ID: 24313044
    [Abstract] [Full Text] [Related]

  • 35. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand.
    Boonruang S, Buppasiri P.
    J Med Assoc Thai; 2005 Apr 26; 88(4):455-9. PubMed ID: 16146247
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria.
    Bukbuk DN, el Nafaty AU, Obed JY.
    Cent Eur J Public Health; 2002 Jun 26; 10(1-2):21-3. PubMed ID: 12096678
    [Abstract] [Full Text] [Related]

  • 37. Fetal risk associated with rubella vaccination during pregnancy.
    Badilla X, Morice A, Avila-Aguero ML, Saenz E, Cerda I, Reef S, Castillo-Solórzano C.
    Pediatr Infect Dis J; 2007 Sep 26; 26(9):830-5. PubMed ID: 17721380
    [Abstract] [Full Text] [Related]

  • 38. Rubella in pregnancy in Israel: 15 years of follow-up and remaining problems.
    Fogel A, Barnea BS, Aboudy Y, Mendelson E.
    Isr J Med Sci; 1996 May 26; 32(5):300-5. PubMed ID: 8641868
    [Abstract] [Full Text] [Related]

  • 39. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
    Bdour S.
    Vaccine; 2006 Apr 12; 24(16):3309-12. PubMed ID: 16460842
    [Abstract] [Full Text] [Related]

  • 40. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y, Wood J, Khandaker G, Waddington C, Snelling T.
    Vaccine; 2016 Nov 04; 34(46):5636-5642. PubMed ID: 27670077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.